Venture Capital Investors

Hippocrates Ventures

Hippocrates Ventures is focused on investing in techn-focused companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Hippocrates Ventures is the world's first social impact digital therapeutics fund which is completely funded by 100 physician investors investing $100K each for a total fund size of $10 million. Digital therapeutics, also known as software as a drug, is the concept of a digital program having a clinical and repeatable outcome to either prevent or treat disease. Digital therapeutics has the potential to prevent and treat major conditions such as diabetes, heart disease, obesity, smoking cessation, alcoholism, stroke, cancer prevention, stress, mental health conditions, and a variety of other diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/4/2018

Transaction History

Our records indicate that Hippocrates Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Managing Director

Laurence Girard

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Hippocrates Ventures has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Hinge Capital | Hiro Capital

Share this article

About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary